Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03867084
What this trial is testing

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

Who this might be right for
Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 959
Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Large-scale testing (Phase 3)Study completedNCT03068455
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,844
Testing effectiveness (Phase 2)Looking for participantsNCT07262489
What this trial is testing

Neo-adjuvant Immunotherapy Master Trial for Localized Cancers

Who this might be right for
Localized Cancer
UNICANCER 200
Not applicableLooking for participantsNCT07754409
What this trial is testing

Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.

Who this might be right for
Non-Small Cell Carcinoma of Lung
Göteborg University 75
Testing effectiveness (Phase 2)Looking for participantsNCT07149363
What this trial is testing

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer (SCLC)
Alliance Foundation Trials, LLC. 65
Testing effectiveness (Phase 2)UnknownNCT05350891
What this trial is testing

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 77
Testing effectiveness (Phase 2)Study completedNCT05775796
What this trial is testing

Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)

Who this might be right for
Non-small Cell Lung CancerStage II-IIIAImmunotherapy+1 more
Fudan University 30
Large-scale testing (Phase 3)Looking for participantsNCT06498635
What this trial is testing

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 306
Large-scale testing (Phase 3)Active Not RecruitingNCT06109779
What this trial is testing

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 760
Early research (Phase 1)Study completedNCT01376505
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Malignant Solid TumourBreast CancerMalignant Tumor of Colon+2 more
Robert Wesolowski 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06977828
What this trial is testing

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Neoadjuvant ImmunotherapyAdjuvant Immunotherapy
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06987734
What this trial is testing

Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 25
Testing effectiveness (Phase 2)UnknownNCT03732430
What this trial is testing

CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients

Who this might be right for
Thoracic Malignancies
Taizhou Hospital 45
Early research (Phase 1)Not Yet RecruitingNCT06195618
What this trial is testing

Personalized Vaccine for TNBC Immunotherapy

Who this might be right for
Breast Cancer Female
Universidad Nacional de Colombia 8
Large-scale testing (Phase 3)Looking for participantsNCT04267848
What this trial is testing

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Who this might be right for
Lung Non-Small Cell CarcinomaLung Non-Small Cell Squamous CarcinomaLung Non-Squamous Non-Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 1,210
Early research (Phase 1)Looking for participantsNCT04157127
What this trial is testing

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CancerPancreatic Adenosquamous Carcinoma
Diakonos Oncology Corporation 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04099251
What this trial is testing

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 790
Testing effectiveness (Phase 2)Study completedNCT03249142
What this trial is testing

Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 69
Not applicableStudy completedNCT00694551
What this trial is testing

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 29
Next Page